TEWKSBURY, Mass., September 8, 2021 (Newswire.com) - Otsuka Group Companies (parent company of Cambridge Isotope Laboratories, Inc.) began to celebrate its 100th anniversary on Sept. 1, 2021. Under ...
Otsuka just posted Q3 2026 earnings, and the stock closed the session at ¥4,352 after a choppy week that included a small ...
On November 2, 2026, the stock price of Otsuka Corporation (4768) experienced a significant drop, falling by over 12% at one ...
Otsuka is facing plenty of bleeding, now that its blockbuster antipsychotic Abilify has generic competition. But the company is working hard to soften the blow, and a brand-new FDA approval for an ...
The US Food and Drug Administration (FDA) has accepted Otsuka Pharmaceutical's biologics licence application for sibeprenlimab for review. The monoclonal antibody selectively inhibits the activity of ...
The company expects full-year 2026 profit attributable to owners of the parent to increase 0.9% year over year to 64.90 billion yen, with basic earnings per share of 171.15 yen. Otsuka closed trading ...
Otsuka and partner Proteus Digital Health envisioned a new version of the antipsychotic Abilify that could track patients and their doses. But the FDA was underwhelmed by the partners' ...
This article has been updated with comments from Proteus and Otsuka. Once valued at $1.5 billion, Proteus Digital Health may now sell to its largest shareholder for $15 million in cash. A Delaware ...
PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce the filing of a New Drug Application ...
PRINCETON, N.J., Nov. 13, 2019 /PRNewswire/ -- Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) today announced that effective January 1, 2020, its long-time President and CEO ...
Over the last year, digital has transformed the caregiver experience, but pharma has also been undergoing a metamorphosis in order to reach patients. During the pandemic, life science companies were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results